OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies

Transplant Proc. 1995 Feb;27(1):852-3.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actuarial Analysis
  • Azathioprine / therapeutic use
  • Belgium
  • Cyclosporine / therapeutic use*
  • Drug Therapy, Combination
  • Graft Rejection / prevention & control*
  • Graft Survival / immunology
  • Graft Survival / physiology*
  • HLA-DR Antigens
  • Histocompatibility Testing
  • Humans
  • Ischemia
  • Kidney Transplantation / immunology
  • Kidney Transplantation / mortality
  • Kidney Transplantation / physiology*
  • Muromonab-CD3 / therapeutic use*
  • Organ Preservation
  • Survival Rate
  • United States

Substances

  • HLA-DR Antigens
  • Muromonab-CD3
  • Cyclosporine
  • Azathioprine